Today’s Pharma News 8/18/2017

Today’s quick-read news highlights brought to you by Impactiviti:

>> Ovarian cancer drug (Merck/AstraZeneca) gets expanded use approval from FDA.

>> $465M: The price tag misclassifying a EpiPen (Mylan)

>> Pfizer gets FDA approval for drug to treat rare ALL cancer.

---

 

Looking to identify the best outsource vendors for your needs? Need on-boarding and developmental training on project/vendor management? AskSteve@Impactiviti.com

PLUS: we share a weekly e-newsletter with helpful recommendations and resources for commercial pharma, biotech, and medical device professionals. Click to join:

–> Sign up for the Impactiviti Connection here

Read Full Post »

Today’s Pharma News 8/16/17

Today’s quick-read news highlights brought to you by Impactiviti:

>> Novartis’ heart drug Entresto – finally gaining market traction.

>> The Top 25 Oncology Brands of 2016: Here’s your list, from Medical Marketing and Media (which company do you think has three of the top five?)

>> Alexion grabs 3 new patents for its lead drug Soliris – can they keep future biosimilars at bay?

---

 

Looking to identify the best outsource vendors for your needs? Need on-boarding and developmental training on project/vendor management? AskSteve@Impactiviti.com

PLUS: we share a weekly e-newsletter with helpful recommendations and resources for commercial pharma, biotech, and medical device professionals. Click to join:

–> Sign up for the Impactiviti Connection here

 

Read Full Post »

Today’s Pharma News 8/15/17

Today’s quick-read news highlights brought to you by Impactiviti:

>> Drug expiration dates: bogus? “Hospitals in the U.S. throw away $800 million worth of unused medicine every year, and pharmacies and consumers trash uncounted millions more, all because they didn’t use or sell those medicines prior to the date printed on the bottle. But according to a new report from ProPublica, most of those drugs are safe and effective for years after the expiration date. And the Food and Drug Administration (FDA) knows it.”

>> Drug + Digital: I think we’ll be seeing a lot more clinical trials like this. (diabetes: Afrezza plus OneDrop)

>> Killing leukemia with mushrooms? – intriguing possibility

---

Looking to identify the best outsource vendors for your needs? Need on-boarding and developmental training on project/vendor management? AskSteve@Impactiviti.com

PLUS: we share a weekly e-newsletter with helpful recommendations and resources for commercial pharma, biotech, and medical device professionals. Click to join:

–> Sign up for the Impactiviti Connection here

 

Read Full Post »

Today’s Pharma News (8/14/17)

Today’s quick-read news highlights brought to you by Impactiviti:

>> Following the money on opioid prescriptions: “One in 12 doctors has received money from drug companies marketing prescription opioid medications…researchers at Boston Medical Center found that from 2013 to 2015, 68,177 doctors received more than $46 million in payments from drug companies pushing powerful painkillers.”

>> A valuable business case study: How does Intuitive Surgical make most of its money? If you immediately thought of “razor blades,” you’re on the right track…

> J&J and the talc wars – no end in sight.

---

Looking to identify the best outsource vendors for your needs? Need on-boarding and developmental training on project/vendor management? AskSteve@Impactiviti.com

PLUS: we share a weekly e-newsletter with helpful recommendations and resources for commercial pharma, biotech, and medical device professionals. Click to join:

–> Sign up for the Impactiviti Connection here

 

---

Looking for career opportunities in commercial training? LTEN has you covered with the latest listings – click here!

Read Full Post »